Continuous glucose monitor use during early pregnancy with type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether using a continuous glucose monitor during pregnancy is useful for people with type 2 diabetes. It may help track blood sugar levels more closely to support safer pregnancy care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You are pregnant with one baby, and you are 14 weeks or less at your first OB visit.
- You have type 2 diabetes confirmed by prior blood sugar test results (like A1c, glucose tolerance, or fasting glucose).
- You plan to get prenatal care and deliver at UMass Memorial Health Care.
- You can understand the study and sign the consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a continuous glucose monitor (a small sensor that tracks your blood sugar) along with support from others can help prevent or manage high blood sugar during pregnancy. It is for pregnant women under 20 weeks who have certain risk factors for gestational diabetes.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
This study tests whether using a CGM (a small sensor that tracks blood sugar) can help manage type 2 diabetes during pregnancy better than standard care. It is for women who have type 2 diabetes and are pregnant with one baby.
This trial tests if using a continuous glucose monitor (CGM) helps manage blood sugar better than finger-stick checks in pregnant women with type 2 diabetes. It aims to see if CGM leads to better sugar control and possibly healthier outcomes for you and your baby.
This study uses a continuous glucose monitor to check blood sugar levels after giving birth in people who had gestational diabetes. It aims to find early signs of abnormal blood sugar and may help you understand your risk for type 2 diabetes.
This trial tests whether using a continuous glucose monitor (CGM) — a small sensor that tracks your blood sugar all the time — helps pregnant women with type 2 diabetes manage their sugar levels. If you take part, you will get a CGM and regular care; the goal is to see if CGM leads to better health for you and your baby.
Hear when a new Type 2 Diabetes Treated With Insulin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.